Taiwan Opens New Center For Phase I, II Drug Trials
This article was originally published in PharmAsia News
Taiwan has opened a university hospital center dedicated to conducting early-stage clinical trials of drugs, with an emphasis on cancer treatments. The National Health Research institutes and the National Cheng Kung University Hospital formed the project to conduct Phase I and Phase II trials. Taiwanese and foreign pharmaceutical companies together already have commissioned the center to conduct trials on about 40 cancer drugs they want to test, about one-fifth of them from local firms. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.